High Flow: Revolutionizing Oxygen Therapy with HiFent Nasal High Flow

The Future of Oxygen Therapy

With the aim of providing a higher flow rate than conventional oxygen treatment, HiFent nasal high flow offers a touch screen interface that allows for precise control during high flow oxygen therapy. This groundbreaking design is an ideal solution for offering FiO2 that can be auto proportional valve controlled, mixed gas with controlled temperature and humidity, resulting in better airway management and improved oxygenation.

One of the key strengths of HiFent nasal high flow is its ability to provide a stable and high FiO2, enhancing the effective ventilation of alveoli. By reducing the dead space of the nasopharynx, it creates an oxygen-enriched storage room in the upper airway, improving breathing efficiency. Additionally, the device promotes alveolar open and increases end-expiratory lung volume, thanks to its low positive end-expiratory pressure.

HiFent nasal high flow also excels in humidification, improving mucosa cleaning function, promoting sputum discharge, and reducing the chance of infection. Patients will experience a high level of comfort and tolerance, leading to better compliance and overall satisfaction.

The clinical applications of HiFent nasal high flow are extensive. It has proven to be highly effective in treating ICU emergency mild and moderate acute respiratory failure, reducing intubation rates and mortality compared to noninvasive ventilation and standard oxygen therapy. The device also offers a new option for patients with acute heart failure or cardiogenic pulmonary edema, improving oxygenation and reducing cardiac load.

Furthermore, HiFent nasal high flow is a valuable tool in assisting bronchoscopy, transesophageal ultrasonography, and digestive endoscopy for hypoxic patients. It provides effective oxygen therapy for chronic respiratory failure, improves ciliary activity, promotes sputum discharge, and reduces the chance of infection. In palliative treatment, it offers a new option for end-stage patients who reject intubation and resuscitation. Additionally, it proves to be a reliable alternative to non-invasive ventilation in cardiothoracic surgery, providing comparable results with enhanced patient comfort.

The HiFent nasal high flow design, with its compact dimensions of 358 mm x 197 mm x 165 mm, is a result of extensive research and collaboration with various departments, including ICU, pneumology, neurology, neurosurgery, chest surgery, general surgery, pediatrics, anesthesiology, and rehabilitation. Its global availability since January 2019 has made it accessible to medical professionals worldwide.

The exceptional design and functionality of HiFent nasal high flow have been recognized with the prestigious Bronze A' Design Award in the Medical Devices and Medical Equipment Design category in 2019. This accolade is a testament to the device's outstanding creativity, resourcefulness, and contribution to improving the quality of life for patients.